By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Titan Pharmaceuticals, Inc. 

400 Oyster Point Boulevard
Suite 505
South San Francisco  California  94080-1921  U.S.A.
Phone: 650-244-4990 Fax: 650-244-4956


SEARCH JOBS


Industry
Biotechnology






Company News
Titan Pharma (TTP) Schedules Conference Call To Review First Quarter 2016 Financial Results 5/5/2016 11:10:37 AM
Titan Pharma (TTP) Announces Presentation Of Probuphine Phase III Data At American Society Of Addiction Medicine Annual Conference 4/18/2016 11:58:42 AM
Titan Pharma (TTP) Reports Full Year And Fourth Quarter 2015 Financial Results 3/16/2016 10:03:03 AM
Titan Pharma (TTP) To Present At 28th Annual ROTH Conference 3/9/2016 11:36:18 AM
Titan Pharma (TTP) Schedules Conference Call To Review Fourth Quarter And Full Year 2015 Financial Results 3/9/2016 11:29:06 AM
Titan Pharma (TTP) Receives Feedback From FDA On Ropinirole Implant Development Program For Parkinson's Disease 3/8/2016 11:20:09 AM
FDA Needs More Time to Review Titan Pharma (TTP)' Probuphine NDA 2/22/2016 5:53:53 AM
Titan Pharmaceuticals (TTP) And Braeburn Pharma Announce FDA Advisory Committee Recommends Approval Of Probuphine, First 6-Month Implant To Treat Opioid Addiction 1/13/2016 6:34:21 AM
Titan Pharmaceuticals (TTP) And Braeburn Pharma Announce Date Of FDA Advisory Committee Review Of Probuphine For Opioid Addiction 12/11/2015 11:02:17 AM
Braeburn Pharma And Titan Pharmaceuticals (TTP) Announce Date Of FDA Advisory Committee Review Of Probuphine For Opioid Addiction 12/9/2015 7:30:38 AM
12345678910...
//-->